CGNH
CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2016 Q1 | -0.00 | $0 | $30,061 |
| 2015 Q4 | -0.00 | $0 | -$133,153 |
| 2015 Q3 | -0.01 | $0 | -$162,748 |
| 2015 Q2 | 0.00 | $0 | -$100,568 |
| 2015 Q1 | -0.01 | $0 | -$210,170 |
| 2014 Q4 | -0.02 | $0 | -$56,124 |
| 2014 Q3 | -0.01 | $0 | -$131,514 |
| 2014 Q2 | -0.01 | $0 | -$192,413 |